Cargando…
Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305
BACKGROUND: The recommended starting dose of eribulin in patients with hepatic impairment is based on the Child-Pugh score, largely informed by a pharmacokinetic study of 18 patients. In the pivotal studies of eribulin in metastatic breast cancer (Study 301 and Study 305 [EMBRACE]), entry criteria a...
Autores principales: | Macpherson, Iain R., He, Yaohua, Palmieri, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977154/ https://www.ncbi.nlm.nih.gov/pubmed/33736675 http://dx.doi.org/10.1186/s13058-021-01407-w |
Ejemplares similares
-
A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairment
por: Palmieri, C., et al.
Publicado: (2021) -
Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021) -
Association of Thyroid Function and Severity of Illness in Liver Cirrhosis as Measured by Child-Pugh Score
por: Raj, Aswin, et al.
Publicado: (2023) -
Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023) -
Effectiveness of the MELD/Na Score and the Child–Pugh Score for the Identification of Palliative Care Needs in Patients with Cirrhosis of the Liver
por: Puentes, Juan Carlos Perdomo, et al.
Publicado: (2018)